91 related articles for article (PubMed ID: 3248110)
1. Structure-activity relationships of synthetic analogues of platelet-activating factor.
Ostermann G; Kertscher HP; Hofmann B; Till U
Biomed Biochim Acta; 1988; 47(10-11):S233-6. PubMed ID: 3248110
[No Abstract] [Full Text] [Related]
2. Platelet-activating factor and analogues: comparative studies with human neutrophils and rabbit platelets.
O'Flaherty JT; Salzer WL; Cousart S; McCall CE; Piantadosi C; Surles JR; Hammett MJ; Wykle RL
Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):291-309. PubMed ID: 6844746
[TBL] [Abstract][Full Text] [Related]
3. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
[No Abstract] [Full Text] [Related]
4. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: comparison with platelet activating factor.
Sugiura T; Tokumura A; Gregory L; Nouchi T; Weintraub ST; Hanahan DJ
Arch Biochem Biophys; 1994 Jun; 311(2):358-68. PubMed ID: 8203898
[TBL] [Abstract][Full Text] [Related]
5. Ethanol modulation of the effects of platelet-activating factor on human platelets and a macrophage cell line.
Baker RC
Prog Clin Biol Res; 1990; 325():113-22. PubMed ID: 2300602
[No Abstract] [Full Text] [Related]
6. Halo lipids. VI. Stimulation of human and rabbit blood platelets by racemic halo analogues of O-alkyl-glycerophosphocholine.
Ostermann G; Brachwitz H; Till U
Biomed Biochim Acta; 1984; 43(3):349-55. PubMed ID: 6743307
[TBL] [Abstract][Full Text] [Related]
7. Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits.
Michibayashi T
Int Angiol; 2002 Sep; 21(3):260-7. PubMed ID: 12384648
[TBL] [Abstract][Full Text] [Related]
8. Role of endogenous arachidonate metabolites in phospholipid-induced human platelet activation.
MacIntyre DE; Shaw AM; Pollock WK; Marks G; Westwick J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():423-8. PubMed ID: 6221557
[No Abstract] [Full Text] [Related]
9. [PAF-antagonists with lipid structure. 6. Alkylpropandiol lipids with acyl- and ether- structures at the C-3 position and heterocyclic head groups; synthesis, characterization and structure-activity relationship].
Kertscher HP
Pharmazie; 1997 Sep; 52(9):672-5. PubMed ID: 9411454
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
12. Biological activity of lipids of pine pollen on platelet aggregation in correlation with the platelet activating factor.
Siafaka-Kapadai A; Demopoulos CA; Andrikopoulos NK
Biochem Int; 1986 Jan; 12(1):33-41. PubMed ID: 3947373
[TBL] [Abstract][Full Text] [Related]
13. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.
McManus LM; Hanahan DJ; Demopoulos CA; Pinckard RN
J Immunol; 1980 Jun; 124(6):2919-24. PubMed ID: 7373056
[No Abstract] [Full Text] [Related]
14. [Platelet aggregation and platelet activating factor (author's transl)].
Chignard M; Vargaftig BB; Benveniste J; Le Couedic JP
J Pharmacol; 1980; 11(4):371-7. PubMed ID: 7206730
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of the activation of rabbit platelets induced by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activation factor)].
Kozlov VK; Filatova LV; Kulikov VI; Markosian RA; Bergel'son LD
Biull Eksp Biol Med; 1985 Oct; 100(10):410-2. PubMed ID: 4052603
[TBL] [Abstract][Full Text] [Related]
16. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions.
Shen Z; Dong Z; Cheng P; Li L; Chen Z; Liu J
Planta Med; 2003 Jul; 69(7):605-9. PubMed ID: 12898414
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis and thrombocyte-aggregating action of a structural analog of platelet activating factor with a modified head group].
Kertscher HP; Ostermann G; Hofmann B
Pharmazie; 1988 Mar; 43(3):211. PubMed ID: 3380866
[No Abstract] [Full Text] [Related]
18. Phospholipids chiral at phosphorus. Synthesis and stereospecificity of phosphorothioate analogues of platelet-activating factor.
Rosario-Jansen T; Jiang RT; Tsai MD; Hanahan DJ
Biochemistry; 1988 Jun; 27(13):4619-24. PubMed ID: 3167004
[TBL] [Abstract][Full Text] [Related]
19. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues.
Ostermann G; Kertscher HP; Till U
Biomed Biochim Acta; 1985; 44(2):K17-23. PubMed ID: 4004829
[TBL] [Abstract][Full Text] [Related]
20. Response of mice and mouse platelets to acetyl glyceryl ether phosphorylcholine.
Lanara E; Vakirtzi-Lemonias C; Kritikou L; Demopoulos CA
Biochem Biophys Res Commun; 1982 Dec; 109(4):1148-56. PubMed ID: 7168759
[No Abstract] [Full Text] [Related]
[Next] [New Search]
